Renaissance Technologies - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,436
-55.9%
647,652
-33.2%
0.01%
-42.9%
Q2 2023$10,054
-0.8%
969,552
-22.6%
0.01%
+7.7%
Q1 2023$10,130
-42.7%
1,252,152
+11.6%
0.01%
-45.8%
Q4 2022$17,668
-99.9%
1,121,752
-5.4%
0.02%
-7.7%
Q3 2022$18,655,000
+0.5%
1,185,178
-10.9%
0.03%
+18.2%
Q2 2022$18,562,000
-26.1%
1,329,678
-8.8%
0.02%
-24.1%
Q1 2022$25,129,000
+3.1%
1,457,578
-13.1%
0.03%
-3.3%
Q4 2021$24,382,000
-33.0%
1,676,878
-17.0%
0.03%
-36.2%
Q3 2021$36,376,000
-14.8%
2,020,878
-16.9%
0.05%
-11.3%
Q2 2021$42,704,000
-43.3%
2,431,878
-18.6%
0.05%
-43.6%
Q1 2021$75,259,000
+255.9%
2,986,478
-8.6%
0.09%
+308.7%
Q4 2020$21,145,000
+139.6%
3,268,178
-4.8%
0.02%
+155.6%
Q3 2020$8,824,000
+66.1%
3,433,390
+4.7%
0.01%
+80.0%
Q2 2020$5,313,000
+60.9%
3,279,840
+3.3%
0.01%
+66.7%
Q1 2020$3,303,000
-37.2%
3,175,636
+14.1%
0.00%
-25.0%
Q4 2019$5,259,000
+147.4%
2,782,297
+41.3%
0.00%
+100.0%
Q3 2019$2,126,000
+38.8%
1,968,716
+181.4%
0.00%
+100.0%
Q2 2019$1,532,000
-40.2%
699,580
+63.7%
0.00%
-50.0%
Q1 2019$2,560,000
+262.1%
427,380
+346.7%
0.00%
+100.0%
Q4 2018$707,000
-9.8%
95,680
+231.1%
0.00%0.0%
Q2 2017$784,000
-70.2%
28,900
-67.2%
0.00%
-75.0%
Q1 2017$2,627,000
-44.6%
88,079
-49.6%
0.00%
-42.9%
Q4 2016$4,739,000174,6000.01%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,258,243$8,618,96513.75%
Foresite Capital Management IV, LLC 2,808,034$19,235,03310.68%
Bain Capital Life Sciences Investors, LLC 3,400,000$23,290,0002.60%
GREAT POINT PARTNERS LLC 1,691,768$11,588,6112.11%
Samsara BioCapital, LLC 696,171$4,768,7711.46%
Altium Capital Management LP 403,000$2,760,5501.44%
BVF INC/IL 7,064,736$48,393,4421.30%
Aisling Capital Management LP 434,455$2,976,0171.23%
GREAT POINT PARTNERS LLC 700,000$4,795,0000.87%
VR Adviser, LLC 1,040,754$7,129,1650.75%
View complete list of ACLARIS THERAPEUTICS INC shareholders